Abstract
Keywords
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to The American Journal of MedicineReferences
- Saphenous vein autograft replacement of severe segmental coronary artery occlusion: operative technique.Ann Thorac Surg. 1968; 5: 334-339
- Transluminal dilatation of coronary artery stenosis.Lancet. 1978; 1: 263
- Optimal medical therapy with or without PCI for stable coronary disease.N Engl J Med. 2007; 356: 1503-1516
- Coronary Disease and Coronary Thrombosis, Atherosclerosis. Heart Disease.MacMillan, New York, NY1931: 410-425
- An evaluation of internal-mammary-artery ligation by a double-blind technic.N Engl J Med. 1959; 260: 1115-1118
- Surgical treatment of angina pectoris.Circulation. 1961; 23: 111-120
- Werner Forssmann and catheterization of the heart.Ann Thorac Surg. 1990; 49 (1929.): 497-499
- Cine coronary arteriography.Mod Concepts Cardiovasc Dis. 1962; 31: 735-738
- Artificial maintenance of the circulation during experimental occlusion of the pulmonary artery.Arch Surg. 1937; 34: 1105-1131
- Evolution of cardiopulmonary bypass.Circulation. 2009; 119: 2844-2853
- Development of an anastomosis between the coronary vessels and a transplanted internal mammary artery.Can Med Assoc J. 1946; 55: 117-119
- Landmarks in Cardiac Surgery.Isis Medical Media, Oxford, UK1997
- Internal mammary-coronary artery anastomosis. A nonsuture method employing tantalum rings.J Thorac Cardiovasc Surg. 1961; 41: 378-386
- Coronary-artery surgery at the crossroads.N Engl J Med. 1977; 297: 661-663
- Treatment of chronic stable angina. A preliminary report of survival data of the randomized Veterans Administration cooperative study.N Engl J Med. 1977; 297: 621-627
- The Veterans Administration Cooperative Study of Stable Angina: current status.Circulation. 1982; 65: 60-67
- Coronary artery surgery study (CASS): a randomized trial of coronary artery bypass surgery. Survival data.Circulation. 1983; 68: 939-950
- Long-term results of prospective randomised study of coronary artery bypass surgery in stable angina pectoris. European Coronary Surgery Study Group.Lancet. 1982; 2: 1173-1180
- A randomized trial of coronary artery bypass surgery. Survival of patients with a low ejection fraction.N Engl J Med. 1985; 312: 1665-1671
- Survival in subgroups of patients with left main coronary artery disease. Veterans Administration Cooperative Study of Surgery for Coronary Arterial Occlusive Disease.Circulation. 1982; 66: 14-22
- Effect of coronary artery bypass graft surgery on survival: overview of 10-year results from randomised trials by the Coronary Artery Bypass Graft Surgery Trialists Collaboration.Lancet. 1994; 344: 563-570
- Ten-year follow-up of quality of life in patients randomized to receive medical therapy or coronary artery bypass graft surgery. The Coronary Artery Surgery Study (CASS).Circulation. 1990; 82: 1647-1658
- Coronary-artery bypass surgery in patients with left ventricular dysfunction.N Engl J Med. 2011; 364: 1607-1616
- Coronary-artery bypass surgery in patients with ischemic cardiomyopathy. N Engl J Med. 2016; 374: 1511-1550
- A randomized trial comparing coronary angioplasty with coronary bypass surgery. Emory Angioplasty versus Surgery Trial (EAST).N Engl J Med. 1994; 331: 1044-1050
- Comparison of coronary bypass surgery with angioplasty in patients with multivessel disease.N Engl J Med. 1996; 335: 217-225
- A randomized study of coronary angioplasty compared with bypass surgery in patients with symptomatic multivessel coronary disease. German Angioplasty Bypass Surgery Investigation (GABI).N Engl J Med. 1994; 331: 1037-1043
- Coronary angioplasty versus coronary artery bypass surgery: the Randomized Intervention Treatment of Angina (RITA) trial.Lancet. 1993; 341: 573-580
- First-year results of CABRI (Coronary Angioplasty versus Bypass Revascularisation Investigation). CABRI Trial Participants.Lancet. 1995; 346: 1179-1184
- Three-year follow-up of the Argentine Randomized Trial of Percutaneous Transluminal Coronary Angioplasty Versus Coronary Artery Bypass Surgery in Multivessel Disease (ERACI).J Am Coll Cardiol. 1996; 27: 1178-1184
- Coronary artery bypass surgery compared with percutaneous coronary interventions for multivessel disease: a collaborative analysis of individual patient data from ten randomised trials.Lancet. 2009; 373: 1190-1197
- Influence of diabetes on 5-year mortality and morbidity in a randomized trial comparing CABG and PTCA in patients with multivessel disease: the Bypass Angioplasty Revascularization Investigation (BARI).Circulation. 1997; 96: 1761-1769
- A comparison of angioplasty with medical therapy in the treatment of single-vessel coronary artery disease. Veterans Affairs ACME Investigators.N Engl J Med. 1992; 326: 10-16
- Coronary angioplasty versus medical therapy for angina: the second Randomised Intervention Treatment of Angina (RITA-2) trial. RITA-2 trial participants.Lancet. 1997; 350: 461-468
- Percutaneous coronary intervention versus conservative therapy in nonacute coronary artery disease: a meta-analysis.Circulation. 2005; 111: 2906-2912
- Arterial Revascularization Therapies Study Group. Comparison of coronary-artery bypass surgery and stenting for the treatment of multivessel disease.N Engl J Med. 2001; 344: 1117-1124
- Coronary artery bypass surgery versus percutaneous coronary intervention with stent implantation in patients with multivessel coronary artery disease (the Stent or Surgery trial): a randomised controlled trial.Lancet. 2002; 360: 965-970
- Effect of PCI on long-term survival in patients with stable ischemic heart disease.N Engl J Med. 2015; 373: 1937-1946
- Effect of PCI on quality of life in patients with stable coronary disease.N Engl J Med. 2008; 359: 677-687
- A randomized trial of therapies for type 2 diabetes and coronary artery disease.N Engl J Med. 2009; 360: 2503-2515
- Effects of optimal medical treatment with or without coronary revascularization on angina and subsequent revascularizations in patients with type 2 diabetes mellitus and stable ischemic heart disease.Circulation. 2011; 123: 1492-1500
- Fractional flow reserve-guided PCI versus medical therapy in stable coronary disease.N Engl J Med. 2012; 367: 991-1001
- Fractional flow reserve-guided PCI for stable coronary artery disease.N Engl J Med. 2014; 371: 1208-1217
- Which is more enduring—FAME or COURAGE.N Engl J Med. 2012; 367: 1059-1061
- Percutaneous coronary intervention in stable angina (ORBITA): a double-blind, randomised controlled trial.Lancet. 2018; 391: 31-40
- Initial coronary stent implantation with medical therapy vs. medical therapy alone for stable coronary artery disease: meta-analysis of randomized controlled trials.Arch Intern Med. 2012; 172: 312-319
- Percutaneous coronary intervention outcomes in patients with stable obstructive coronary artery disease and myocardial ischemia: a collaborative meta-analysis of contemporary randomized clinical trials.JAMA Intern Med. 2014; 174: 232-240
- Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease.N Engl J Med. 2009; 360: 961-972
Kappetein AP, Feldman TE, Mack MJ, et al. Comparison of coronary bypass surgery with drug-eluting stenting for the treatment of left main and/or three-vessel disease: 3-year follow-up of the SYNTAX trial. Eur Heart J. 32:2125-2134.
- Coronary artery bypass graft surgery versus percutaneous coronary intervention in patients with three-vessel disease and left main coronary disease: 5-year follow-up of the randomised, clinical SYNTAX trial.Lancet. 2013; 381: 629-638
Farkouh ME, Domanski M, Sleeper LA, et al. Strategies for multivessel revascularization in patients with diabetes. N Engl J Med. 367:2375-2384.
- Everolimus-eluting stents or bypass surgery for left main coronary artery disease.N Engl J Med. 2016; 375: 2223-2235
- Percutaneous coronary angioplasty versus coronary artery bypass grafting in treatment of unprotected left main stenosis (NOBLE): a prospective, randomised, open-label, non-inferiority trial.Lancet. 2016; 388: 2743-2752
- Mortality after coronary artery bypass grafting versus percutaneous coronary intervention with stenting for coronary artery disease: a pooled analysis of individual patient data.Lancet. 2018; 391: 939-948
- International Study of Comparative Health Effectiveness with Medical and Invasive Approaches (ISCHEMIA) Trial: Rationale and design.Am Heart J. 2018; 201: 124-135
- Effect of arterial revascularisation on survival: a systematic review of studies comparing bilateral and single internal mammary arteries.Lancet. 2001; 358: 870-875
- Effect of bilateral internal mammary artery grafts on long-term survival: a meta-analysis approach.Circulation. 2014; 130: 539-545
- Randomized trial of bilateral versus single internal-thoracic-artery grafts.N Engl J Med. 2016; 375: 2540-2549
- Associations between adding a radial artery graft to single and bilateral internal thoracic artery grafts and outcomes: insights from the Arterial Revascularization Trial.Circulation. 2017; 136: 454-463
- Radial-artery or saphenous-vein grafts in coronary-artery bypass surgery.N Eng J Med. 2018; 378: 2069-2077
- Chronic total occlusion percutaneous coronary intervention: evidence and controversies.J Am Heart Assoc. 2018; 7e006732https://doi.org/10.1161/JAHA.117.006732
- Hybrid coronary revascularization versus on-pump coronary artery bypass grafting.Ann Thorac Surg. 2018; 105: 1330-1335
- Hybrid coronary revascularization in selected patients with multivessel disease: 5-year clinical outcomes of the prospective randomized pilot study.JACC Cardiovasc Interv. 2018; 11: 847-852
- ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS: the Task Force for dual antiplatelet therapy in coronary artery disease of the European Society of Cardiology (ESC) and of the European Association for Cardio-Thoracic Surgery (EACTS).Eur Heart J. 2018; 39: 213-260
- Introduction to the STS National Database Series: Outcomes analysis, quality improvement, and patient safety.Ann Thorac Surg. 2015; 100: 1992-2000
- The National Cardiovascular Data Registry (NCDR) Data Quality Brief: the NCDR Data Quality Program in 2012.J Am Coll Cardiol. 2012; 60: 1484-1488
- The American College of Cardiology-National Cardiovascular Data Registry (ACC-NCDR): building a national clinical data repository.J Am Coll Cardiol. 2001; 37: 2240-2245
- Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes.N Engl J Med. 2015; 373: 2117-2128
- Canagliflozin and cardiovascular and renal events in type 2 diabetes.N Engl J Med. 2017; 377: 644-657
- A tale of coronary artery disease and myocardial infarction.N Engl J Med. 2012; 366: 54-63
- Explaining the decrease in U.S. deaths from coronary disease, 1980–2000.N Engl J Med. 2007; 356: 2388-2396
- Heart disease and stroke statistics—2018 update: a report from the American Heart Association.Circulation. 2018; 137: e67-e492
- Prevalence and predictors of cholesterol screening, awareness, and statin treatment among US Adults with familial hypercholesterolemia or other forms of severe dyslipidemia (1999-2014).Circulation. 2018; 137: 2218-2230
- Compliance with guideline-directed medical therapy in contemporary coronary revascularization trials.J Am Coll Cardiol. 2018; 71: 591-602
Article Info
Publication History
Footnotes
Funding: None.
Conflict of Interest: None.
Authorship: There are no primary data in this study. All authors contributed substantially to the writing of this manuscript.